EqualOcean uses cookies to improve functionality and performance of this site. More information could be found in our Privacy Policy. By continuing to browse this site, you consent to the use of cookies.

Thank you for subscribing.

Please check your email to confirm.

Unsubscribe success..

You already subscribed and confirmed.

Please check your email.

You already subscribed.

Please check your email to confirm.

Yusuf I. Tuna

Yusuf I. Tuna

Yusuf I. Tuna is covering healthcare, big data and machine learning related growth-stage Chinese companies. He is experienced in China's IT industry, and from an economics background.

Chinese Immuno-Oncology Firm I-Mab's IPO Lands on NASDAQ
Chinese Immuno-Oncology Firm I-Mab's IPO Lands on NASDAQ
Following its lucrative primary market days, I-Mab Biopharma is seeking new funds from the public on January 16th.
Healthcare Jan. 16, 2020
Following its lucrative primary market days, I-Mab Biopharma is seeking new funds from the public on January 16th.
Chinese Biopharma and Health Tech to Show Up at JPMorgan's Event on Jan 15
Chinese Biopharma and Health Tech to Show Up at JPMorgan's Event on Jan 15
Growth-seeking Chinese healthcare firms will be looking for lucrative deals at the major 'artery' of healthcare private equity at the Westin Hotel on January 15.
Healthcare Jan. 14, 2020
Growth-seeking Chinese healthcare firms will be looking for lucrative deals at the major 'artery' of healthcare private equity at the Westin Hotel on January 15.

MOST READ

Meet Innovax, China's First HPV Vaccine Developer
Meet Innovax, China's First HPV Vaccine Developer
The first Chinese-made HPV vaccine was approved for use in China last week, in a move to tackle a common, pernicious sexually transmitted infection.
Healthcare Jan. 10, 2020
Healthcare
Temasek-backed Transcenta Gets USD 100 million to Develop 'Better Antibodies'
Temasek-backed Transcenta Gets USD 100 million to Develop 'Better Antibodies'
Another capital injection shows China's oncology biotech scene continues to draw the attention of life-science investors.
Healthcare Jan. 8, 2020
Healthcare
Beijing Backs Private Genome Analysis Firm Geneseeq
Beijing Backs Private Genome Analysis Firm Geneseeq
Mainland Chinese companies are set to reign globally in a relatively new field of genome analysis.
Healthcare Dec. 26, 2019
Healthcare
Half a Billion Yuan Flows into Chinese Shared Powerbank Project, SoftBank Leads
Half a Billion Yuan Flows into Chinese Shared Powerbank Project, SoftBank Leads
The Chinese sharing economy ecosystem's recent past has seen numerous scandals and failed projects – but shared battery businesses have proven to have agility, so far.
Manufacturing Dec. 25, 2019
Manufacturing
Cybersecurity SaaS Firm Elex Secures New Funding to Serve China's Cloud Economy
Cybersecurity SaaS Firm Elex Secures New Funding to Serve China's Cloud Economy
A Nanjing-based cybersecurity firm that mainly sells to local government institutions secured over CNY 150 million in its Series C funding round.
Software Dec. 24, 2019
Software
Tencent Touches CNY 10 Billion in Cloud Revenue, Challenging Domestic Contenders
Tencent Touches CNY 10 Billion in Cloud Revenue, Challenging Domestic Contenders
Tencent's cloud services surpassed the CNY 10 billion annual revenue milestone on the eve of 2020, bringing new dimensions for the Internet giant across industry operations in the new year.
High Tech Dec. 21, 2019
High Tech
ByteDance Covertly Invests in a Beijing-based 5G Networking Equipment Firm
ByteDance Covertly Invests in a Beijing-based 5G Networking Equipment Firm
Chinese TikTok-owner ByteDance has invested in a Beijing-based 5G startup, raising questions about the new media behemoth's direction in 2020, and beyond.
High Tech Dec. 17, 2019
High Tech
‘Medical Aesthetic Platform’ So-Young Faces Dilemma: Sell Adds or Retain Trust?
‘Medical Aesthetic Platform’ So-Young Faces Dilemma: Sell Adds or Retain Trust?
The Chinese medical aesthetic marketplace So-Young’s revenue generation model has become more dependent on advertising fees collected from small and underground clinics – and it doesn't seem there is an easy exit from that dead-end road.
Healthcare Dec. 12, 2019
Healthcare
EqualOcean Presents: The 30 Foreign Entrepreneurs in China 2019
Dec. 8, 2019
EqualOcean Presents: The 30 Foreign Entrepreneurs in China 2019
Surging demand from the growing middle class, incentives from local governments and a burgeoning business ecosystem – China has never been so attractive for foreigners looking to build a business. EqualOcean presents ‘The 30 Foreign Entrepreneurs in China 2019.’
Dec. 8, 2019
AI

EqualOcean Presents: The 30 Foreign Entrepreneurs in China 2019

by Yusuf I. Tuna Dec. 8, 2019
Healthtech: Trends and Startups 2019
Dec. 7, 2019
Healthtech: Trends and Startups 2019
Next Global Tech 50
Dec. 7, 2019
Healthcare

Healthtech: Trends and Startups 2019

by Yusuf I. Tuna Dec. 7, 2019
Recruitment App Boss Zhipin Bags Series E from Tencent, Speculate Chinese Media
Nov. 28, 2019
Recruitment App Boss Zhipin Bags Series E from Tencent, Speculate Chinese Media
Boss Zhipin – whose CEO had eyed going public at the end of this year in the US – has been said to have raised a Series E funding round from Tencent.
Nov. 28, 2019
Software

Recruitment App Boss Zhipin Bags Series E from Tencent, Speculate Chinese Media

by Yusuf I. Tuna Nov. 28, 2019
Meet LinkingMed, the Chinese Startup Who Wants to Redefine Radiotherapy
Nov. 25, 2019
Meet LinkingMed, the Chinese Startup Who Wants to Redefine Radiotherapy
EqualOcean sat down with the CEO of LinkingMed to get a glimpse into his business. The following is a recap of our conversation on how the Chinese startup is striving to flourish in the oncology field with its cutting-edge technologies.
Nov. 25, 2019
Healthcare

Meet LinkingMed, the Chinese Startup Who Wants to Redefine Radiotherapy

by Yusuf I. Tuna Nov. 25, 2019
CICC and Vivo Capital Inject CNY 500 mn into Genetron, it Applies IPO in the US
Nov. 21, 2019
CICC and Vivo Capital Inject CNY 500 mn into Genetron, it Applies IPO in the US
Genetron has secured over CNY 500 million from state-backed CICC's healthcare arm and healthcare-focused investment firm Vivo Capital. Just after the announcement, the firm applied for an IPO in the US to raise USD 100 more on November 21.
Nov. 21, 2019
Healthcare

CICC and Vivo Capital Inject CNY 500 mn into Genetron, it Applies IPO in the US

by Yusuf I. Tuna Nov. 21, 2019
Alibaba Buys 4% of Meinian Onehealth, China's Largest Medical Checkup Provider
Nov. 17, 2019
Alibaba Buys 4% of Meinian Onehealth, China's Largest Medical Checkup Provider
Alibaba, a conglomerate that is operating in tens of industries including healthcare, has subscribed over 4% of Meinian Onehealth's shares worth CNY 1.8 billion.
Nov. 17, 2019
Healthcare

Alibaba Buys 4% of Meinian Onehealth, China's Largest Medical Checkup Provider

by Yusuf I. Tuna Nov. 17, 2019
Biotech in China: Oasis in the Desert?
Nov. 12, 2019
Biotech in China: Oasis in the Desert?
Following AstraZeneca's USD 1 billion-large capital injection plans with China's state-backed CICC, and I-Mab Biopharma's long-anticipated IPO, all eyes are back on China's lucrative Biotech scene. EqualOcean sums up the story.
Nov. 12, 2019
Healthcare

Biotech in China: Oasis in the Desert?

by Yusuf I. Tuna Nov. 12, 2019
Yuanxin Huibao CEO: Our Motto is "Cancer Treatment for all Chinese"
Nov. 8, 2019
Yuanxin Huibao CEO: Our Motto is "Cancer Treatment for all Chinese"
On November 6, EqualOcean held a meeting with Peng Xuan, co-CEO of Yuanxin Huibao, getting a glimpse into his insurance firm's business. Here is how the 'insurance products for cancer' got started in China – and got successful.
Nov. 8, 2019
Healthcare

Yuanxin Huibao CEO: Our Motto is "Cancer Treatment for all Chinese"

by Yusuf I. Tuna Nov. 8, 2019
READ MORE

EqualOcean is an international information service provider and investment research firm that aims to become a global platform for industrial innovation.

We strive to make technology inclusive, accessible and transparent.

Join over 70,000 of your peers

Privacy Terms of service Copyright

Copyright ©2019 EqualOcean.com. All rights reserved.